Protalix BioTherapeutics
PLX
#8879
Rank
C$0.23 B
Marketcap
C$2.96
Share price
1.90%
Change (1 day)
37.33%
Change (1 year)

EPS for Protalix BioTherapeutics (PLX)

EPS in 2025 (TTM): C$0.02393

According to Protalix BioTherapeutics 's latest financial reports the company's current EPS (TTM) is C$0.02765. In 2024 the company made an earnings per share (EPS) of C$0.05530 a decrease over its 2023 EPS that were of C$0.17.

EPS history for Protalix BioTherapeutics from 1996 to 2025

Annual EPS

Year EPS Change
2025 (TTM)C$0.02393-56.74%
2024C$0.05530-66.67%
2023C$0.17-138.71%
2022C-$0.43-50%
2021C-$0.86181.82%
2020C-$0.30-82.11%
2019C-$1.70-31.67%
2018C-$2.49-72.31%
2017C-$8.99124.14%
2016C-$4.01-147.54%
2015C$8.43-290.63%
2014C-$4.426.67%
2013C-$4.15130.77%
2012C-$1.80-69.77%
2011C-$5.9419.44%
2010C-$4.98-12.2%
2009C-$5.6736.67%
2008C-$4.15-37.5%
2007C-$6.6450%
2006C-$4.423.23%
2005C-$4.29138.46%
2004C-$1.80-74%
2003C-$6.91-0%
2002C-$6.91-50%
2001C-$13.83233.33%
2000C-$4.15-84.21%
1999C-$26.27-24%
1998C-$34.56-600%
1997C$6.91-16.67%
1996C$8.30

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Pfizer
PFE
C$1.81 6,450.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
C$9.28 33,450.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Amicus Therapeutics
FOLD
C-$0.15-650.00%๐Ÿ‡บ๐Ÿ‡ธ USA
Teva Pharmaceutical Industries
TEVA
C$1.89 6,750.00%๐Ÿ‡ฎ๐Ÿ‡ฑ Israel